14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
DEA vs DOC: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
DOC Overall Winner
6-Pillar Tally: DEA 3 – 3 DOC
Matrix Metrics: DEA 3 – 7 DOC
As of Nov 17, 2026, Healthpeak Properties, Inc. (DOC) is the stronger overall head-to-head candidate over Easterly Government Properties, Inc. (DEA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). DEA carries a Unified Composite Score of 45.1/100 (HOLD) at $21.76 (46.1x Forward P/E, 25.2% operating margin), whereas DOC carries 54.0/100 (HOLD) at $19.36 (141.7x Forward P/E, 15.7% operating margin).
Technical & Structure Timing Caution: DEA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.3); meanwhile DOC is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DEA vs DOC. Trailing 12-month operating profitability (DEA 25.2% vs DOC 15.7%) and valuation multiples (DEA 46.1x vs DOC 141.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the REIT - Office value chain with $1.1B market capitalization and 25.2% operating margin.
OpEx & R&D Reinvestment42.3% of Rev ($157M)
90D Engineering Disclosures0 Published
DOC Moat ProfileScale & Operating Efficiency Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $14.5B market capitalization and 15.7% operating margin.
OpEx & R&D Reinvestment40.4% of Rev ($1.24B)
90D Engineering Disclosures0 Published
Investor FAQ DEA vs DOC Key Questions & Quantitative Answers
As of Nov 17, 2026, Healthpeak Properties, Inc. (DOC) is the stronger overall head-to-head candidate over Easterly Government Properties, Inc. (DEA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). DEA carries a Unified Composite Score of 45.1/100 (HOLD) at $21.76 (46.1x Forward P/E, 25.2% operating margin), whereas DOC carries 54.0/100 (HOLD) at $19.36 (141.7x Forward P/E, 15.7% operating margin). Technical & Structure Timing Caution: DEA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.3); meanwhile DOC is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
DOC leads the Growth & Scale pillar: DEA posts +8.8% YoY revenue growth and +450.0% YoY earnings growth on $371M TTM revenue (67.5% gross margin, 25.2% operating margin), compared with DOC at +16.3% YoY revenue growth and +68.2% YoY earnings growth on $3.06B TTM revenue (56.1% gross margin, 15.7% operating margin). On trailing 12-month operating scale, DEA generates $371M in USD-normalized revenue versus $3.06B for DOC. In operating R&D and SG&A reinvestment, DEA deploys 42.3% of Rev ($157M) (0 90-day corporate R&D disclosures) versus 40.4% of Rev ($1.24B) (0 disclosures) for DOC.
DOC screens cheaper on headline valuation multiples. DEA trades at 46.1x Forward P/E, 76.1x Trailing P/E, N/M PEG, and 7.4x EV/Revenue (43.4% FCF margin), whereas DOC trades at 141.7x Forward P/E, 37.0x Trailing P/E, 4.08x PEG, and 4.7x EV/Revenue (51.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DEA (1.1% ROE) versus DOC (4.4% ROE) capital efficiency.
In options market volatility and institutional positioning, DEA carries 34.7% implied volatility (8th %ile, Compressed (<25th %ile)), a 4.08x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.31β · 26% Vol realized risk). By comparison, DOC carries 20.7% implied volatility (25th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.38β · 29% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.